You are browsing the archive for Type 1 - Diabetes Agent.

by

Good news for Type 1 Diabetics: Life expectancy has improved dramatically

September 4, 2012 in News

According to the results of a study recently published in the journal Diabetes, the life expectancy for those diagnosed with type 1 diabetes has saw a huge jump over the last half of the 20th century.

Researchers at the University of Pittsburgh compared data on two groups of participants diagnosed with type 1 diabetes before age 17. The first group were diagnosed with diabetes between 1950 and 1964. The second group received their diagnosis between 1965 and 1980. Read the rest of this entry →

by

Tuberculosis vaccine offers new hope for treating Type 1 Diabetes

September 4, 2012 in News

Bacille Calmette-Guerin (BCG) is a mouthful, but it has been used successfully to combat tuberculosis for the past 90 years. These days, it is also used as a treatment for bladder cancer. Now, a small study has provided preliminary evidence that this vaccine could help fight type 1 diabetes as well.

The vaccine increases levels of a substance naturally produced in the body, tumor necrosis factor (TNF). High levels of TNF are toxic, but BCG does not seem to raise levels of TNF high enough for this to happen. Read the rest of this entry →

by

New glucagon formula may be suitable for the artificial pancreas

September 4, 2012 in News

As you know, glucagon is a naturally occurring hormone that normally protects the body from hypoglycemia by raising blood sugar levels when they dip below a healthy level. In someone without diabetes, glucagon and insulin complement each other, responding to fluctuations in blood sugar to keep glucose levels within a healthy range. Read the rest of this entry →

by

The artificial pancreas gets its first U.S. outpatient test drive

September 4, 2012 in News

Justin Wood, a 40-year-old diagnosed with type 1 diabetes 28 years ago, recently became the first person enrolled in a clinical trial to try out a newly-developed artificial pancreas outside of the hospital. The device, developed by the multinational Artificial Pancreas Project supported by the Juvenile Diabetes Research Foundation, is a handheld device that ties a reconfigured smartphone into a patient’s insulin pump and continuous glucose monitor (CGM). Read the rest of this entry →